Generation of fully human anti-GPC3 antibodies with high-affinity recognition of GPC3 positive tumors
{{output}}
The acceleration of therapeutic antibody development has been motivated by the benefit to and their demand for human health. In particular, humanized transgenic antibody discovery platforms, combined with immunization, hybridoma fusion and/or single cell DNA s... ...